Beschreibung
Oral treatment protocol showing that rats received daily nanoencapsulated curcumin for 14 days beginning on day 22 of the Alzheimer disease induction model. Group assignments and dosing details are summarized.
Figure 2
DiagramSource Paper
Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzheimer Disease Model.Cite This Figure
![Figure 2: Oral treatment protocol showing that rats received daily nanoencapsulated curcumin for 14 days beginning on day 22 of the Alzheimer disease induction model. Group assignments and dosing details are summarized.]() > Source: Anne Suély Pinto Savall et al. "Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzh." *Brain sciences*, 2024. PMID: [38391705](https://pubmed.ncbi.nlm.nih.gov/38391705/)
<figure> <img src="" alt="Oral treatment protocol showing that rats received daily nanoencapsulated curcumin for 14 days beginning on day 22 of the Alzheimer disease induction model. Group assignments and dosing details are summarized." /> <figcaption>Figure 2. Oral treatment protocol showing that rats received daily nanoencapsulated curcumin for 14 days beginning on day 22 of the Alzheimer disease induction model. Group assignments and dosing details are summarized.<br> Source: Anne Suély Pinto Savall et al. "Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzh." <em>Brain sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38391705/">38391705</a></figcaption> </figure>